Mouse Mesenchymal Stem Cell Marker Antibody Panel SC018 from R&D Systems | Biocompare.com
CD44: More than a mere stem cell marker - ScienceDirect
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties | PLOS ONE
Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress | Cell Death & Disease
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis | Scientific Reports
CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours - eBioMedicine
Identification of CD44 as a cell surface marker for Müller glia precursor cells - Shinoe - 2010 - Journal of Neurochemistry - Wiley Online Library
Effector Memory Th1 CD4 T Cells Are Maintained in a Mouse Model of Chronic Malaria | PLOS Pathogens
Surface expression of lymphoid lineage markers and hCD25 by thymus... | Download Scientific Diagram
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
CD44 antibody (CL488-65117) | Proteintech
A Fountain of Youth for T cell Function
The Challenge of Tumor Heterogeneity – Different Phenotypes of Cancer Stem Cells in a Head and Neck Squamous Cell Carcinoma Xenograft Mouse Model | In Vivo
Identification of mouse mesenchymal stem cell markers in SG-2,-3,-5,... | Download Scientific Diagram
FITC Rat Anti-Mouse CD44
Mouse Naive/Memory T cell ID Panel | ABIN2669200
CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure | Scientific Reports
Mouse Mesenchymal Marker Antibody Panel (SC018): R&D Systems
Single-cell transcriptomics identifies CD44 as a marker and regulator of endothelial to haematopoietic transition | Nature Communications
Biomedicines | Free Full-Text | Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas